The Effect of Darapladib on Plasma Lipoprotein-Associated Phospholipase A2 Activity and Cardiovascular Biomarkers in Patients With Stable Coronary Heart Disease or Coronary Heart Disease Risk Equivalent: The Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

✍ Scribed by Emile R. Mohler III; Christie M. Ballantyne; Michael H. Davidson; Markolf Hanefeld; Luis M. Ruilope; Joel L. Johnson; Andrew Zalewski

• Book ID: 119267268
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 265 KB
• Volume: 51
• Category: Article
• ISSN: 1558-3597
• DOI: 10.1016/j.jacc.2007.11.079